Novel method to control release of lipophilic drugs with high potency from silicone

Chemical and Pharmaceutical Bulletin

Volumn 51, Issue 1, 2003, Pages 11-14

  Kajihara, Masako ^a   Sugie, Toshihiko ^a   Sano, Akihiko ^a   Fujioka, Keiji ^a   Urabe, Yosuke ^b   Tanihara, Masao ^c   Imanishi, Yukio ^c  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^b Dow Corning Asia Ltd   (Japan)

^c NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Controlled release; Diffusion; Lipophilic drug; Silicone

Indexed keywords

COLECALCIFEROL; DRUG CARRIER; HUMAN SERUM ALBUMIN; SILASTIC; SILICONE; SOLVENT; AZO COMPOUND; LIPID; SILICONE DERIVATIVE; SUDAN II;

ARTICLE; BINDING AFFINITY; CONTROLLED DRUG RELEASE; DIFFUSION; DRUG BINDING; DRUG FORMULATION; DRUG POTENCY; DRUG SAFETY; DRUG SOLUBILITY; LIPOPHILICITY; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE; CHEMISTRY; METHODOLOGY; PHARMACEUTICS;

AZO COMPOUNDS; CHEMISTRY, PHARMACEUTICAL; CHOLECALCIFEROL; DRUG CARRIERS; LIPIDS; SILICONES; TECHNOLOGY, PHARMACEUTICAL;

EID: 0038266825     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.51.11     Document Type: Article

References (13)

1. Roseman T. J., J. Pharm. Sci., 61, 46-50 (1972).
2. Roseman T. J., "Controlled Release of Biologicaly Active Agents," Plenum Press, New York, 1974, pp. 105-112.
3. Pfister W. R., Sweet R. P., Weaver M. E., Walters P. A., Proc. Int. Symp. Control. Release Bioact. Mater., 12, 145-146 (1985).
4. Pfister W. R, Sheeran M. A., Watters D. E., Sweet R. P., Walters P. A., Proc. Int. Symp. Control. Release Bioact. Mater., 14, 223-224 (1987).
5. Moreau J. C., Leclerc B., Mazan J., Couarraze G., J. Mater. Sci., 2, 243-247 (1991).
6. Posti J., S.T.P. Pharma., 3, 309-312 (1987).
7. Ferguson T. H., Needham G. T., Wagner J. F., J. Control. Release, 8, 45-54 (1988).
8. Baker R. W., Lonsdale H. K., "Controlled Release of Biologicaly Active Agents," Plenum Press, New York, 1974, pp. 15-71.
9. Kajihara M., Sugie T., Hojo T., Maeda H., Sano A., Fujioka K., Sugawara S., Urabe Y., J. Control. Release, 73, 279-291 (2001).
10. Kajihara M., Sugie T., Mizuno M., Tamura N., Sano A., Fujioka K., Kashiwazaki Y., Yamaoka T., Sugawara S., Urabe Y., J. Control. Release, 66, 49-61 (2000).
11. Intervirew form of Rocaltrol®.
12. Proceedings of the workshop, potential effects of reducing carotenoid levels on human health, held at the Harvard School of Public Health, January 17, 1996.
13. Information of General Electric Company.